打破最后的障碍:在脂质纳米颗粒中的阴离子和电离性脂质结构的演变,以逃离内分体
Kaitlin Mrksich1, Marshall S Padilla1, Michael J Mitchell2
1Department of Bioengineering, School of Engineering and Applied Science, University of Pennsylvania, Philadelphia, PA 19104, USA.
Advanced drug delivery reviews
|September 18, 2024
概括
脂质纳米颗粒 (LNPs) 通过保护载荷和帮助细胞进入来增强核酸治疗的传递. 合理的脂质设计是克服内体壁垒和提高治疗疗效的关键.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 药物运输 药物运输 药物运输
背景情况:
- 核酸疗法依靠纳米技术进行安全和有针对性的治疗.
- 纳米粒子保护核酸免受降解,并促进细胞吸收.
- 内体逃生仍然是一个主要的障碍,限制了核酸载荷的细胞质输送.
研究的目的:
- 审查核酸输送的脂质结构的演变.
- 专注于结构-功能关系,特别是对于内体体逃生.
- 检查电离性脂质设计的进展和未来的方向.
主要方法:
- 基于脂质的药物输送系统的文献综述.
- 脂质结构的分析,从阴离子脂质到电离性脂质.
- 专注于影响内体逃逸的结构-功能关系.
主要成果:
- 脂质纳米颗粒 (LNP) 已成为临床核酸输送的关键,mRNA疫苗就是一个例子.
- 脂质的合理设计,特别是电离性脂质,对于克服内体壁垒至关重要.
- 在优化脂质以增强内体逃生方面取得了重大进展.
结论:
- 脂质设计对于核酸治疗的成功至关重要.
- 电离性脂质是实现强大的内体体逃脱的关键进展.
- 脂质结构的持续创新有望进一步推进核酸输送技术.
相关概念视频
Intralumenal Vesicles and Multivesicular Bodies
3.4K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.4K
Maturation of Endosomes
4.2K
The early endosome containing internalized molecules matures through transformations in its location, morphology, intraluminal pH, and membrane protein composition. Together, these changes result in a more acidic late endosome that contains multiple intraluminal vesicles; therefore, the late endosome is also called a multivesicular body (MVB).
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
Changes in location
The maturing endosome moves along microtubules from the periphery of the cell towards the perinuclear region. This movement of the...
4.2K
Receptor-mediated Endocytosis
104.1K
Overview
104.1K
Clathrin Coated Vesicles
6.9K
Clathrin-coated vesicles use endocytosis to transport receptors and lysosomal hydrolases from the Golgi to the lysosome in the late secretory pathway. Clathrin-mediated endocytosis was the first described endocytic process, and Clathrin-coated vesicles remain one of the most well-studied transport vesicles. The molecular machinery that generates clathrin-coated vesicles comprises over 50 proteins that precisely coordinate vesicle formation. Cell surface receptors concentrated in indented sites...
6.9K


